Moderna, Inc. (MRNA) Q4 2025 Earnings Call

Investor webinar replay

Watch the replay and follow the connected company analysis, news, and investor updates for Moderna, Inc..

Watch the replay

Replay transcript excerpt

WEBVTT 00:00:00.031 -- 00:00:03.937 Good day and thank you for standing by. Welcome to Moderna fourth quarter 2025 conference 00:00:03.937 -- 00:00:07.483 call. At this time, all participants are in a listen-only mode. 00:00:07.483 -- 00:00:10.448 After the speaker's presentation, there will be a question and answer session. 00:00:10.448 -- 00:00:13.814 To ask a question during the session, you'll need to press star 1-1 on your telephone. 00:00:13.814 -- 00:00:16.699 You will then hear an automated message advising your hand is raised. 00:00:16.699 -- 00:00:18.982 To withdraw your question, please press star 1-1 again. 00:00:18.982 -- 00:00:21.947 Please be advised, today's conference is being recorded. 00:00:21.947 -- 00:00:24.792 I would now like to hand the conference over to your speaker today, Lavina Talukdar, 00:00:24.792 -- 00:00:27.166 head of IR. Please go ahead. 00:00:27.166 -- 00:00:31.472 Thank you, Kevin. Good morning, everyone. And thank you for joining us on today's call 00:00:31.472 -- 00:00:35.458 to discuss Moderna's fourth quarter 2025 financial 00:00:35.458 -- 00:00:40.846 results and business updates. You can access the press release issued this morning, 00:00:40.846 -- 00:00:45.392 as well as the slides that we'll be reviewing by going to the investor section of our 00:00:45.392 -- 00:00:47.035 website. 00:00:47.035 -- 00:00:52.302 On today's call are Stéphane Boncel, our chief executive officer, Stephen Hogue, 00:00:52.302 -- 00:00:56.613 our president, and Jamie Moth, our chief financial officer. 00:00:56.613 -- 00:01:02.160 Before we begin, please note that this conference call will include forward-looking statements 00:01:02.160 -- 00:01:07.528 made pursuant to the safe harbor provisions of the Private Securities Litigation 00:01:07.528 -- 0...